The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 661-667

  Takeda, Katsuyuki ^a   Thurman, Joshua M ^b   Tomlinson, Stephen ^c   Okamoto, Masakazu ^a   Shiraishi, Yoshiki ^a   Ferreira, Viviana P ^d   Cortes, Claudio ^d   Pangburn, Michael K ^e   Holers, V Michael ^b   Gelfand, Erwin W ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT FACTOR H; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR 2 COMPLEMENT FACTOR H COMPLEMENT REGULATORY REGION FUSION PROTEIN; COMPLEMENTARY DNA; GAMMA INTERFERON; IC3B C3D BINDING REGION OF COMPLEMENT RECEPTOR 2 FACTOR H INHIBITORY REGION FUSION PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; UNCLASSIFIED DRUG;

AIRWAY HYPERRESPONSIVENESS; AIRWAY RESISTANCE; ALLERGIC ASTHMA; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOCKING FACTOR; CELL INFILTRATION; COMPLEMENT ALTERNATIVE PATHWAY; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HYPERSENSITIVITY REACTION; IMMUNOHISTOLOGY; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TARGETING; RECEPTOR BINDING;

ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; OVALBUMIN;

EID: 84855998505     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101813     Document Type: Article

References (34)

1. Levine, S. J., and S. E. Wenzel. 2010. Narrative review: the role of Th2 immune pathway modulation in the treatment of severe asthma and its phenotypes. Ann. Intern. Med. 152: 232-237.
2. Finkelman, F. D., S. P. Hogan, G. K. Hershey, M. E. Rothenberg, and M. Wills-Karp. 2010. Importance of cytokines in murine allergic airway disease and human asthma. J. Immunol. 184: 1663-1674.
3. Taube, C., J. M. Thurman, K. Takeda, A. Joetham, N. Miyahara, M. C. Carroll, A. Dakhama, P. C. Giclas, V. M. Holers, and E. W. Gelfand. 2006. Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc. Natl. Acad. Sci. USA 103: 8084-8089. (Pubitemid 43801056)
4. Mizutani, N., T. Nabe, and S. Yoshino. 2009. Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J. Immunol. 183: 4039-4046.
5. Zhang, X., I. P. Lewkowich, G. Köhl, J. R. Clark, M. Wills-Karp, and J. Köhl. 2009. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells. J. Immunol. 182: 5123-5130.
6. Taube, C., Y.-H. Rha, K. Takeda, J. W. Park, A. Joetham, A. Balhorn, A. Dakhama, P. C. Giclas, V. M. Holers, and E. W. Gelfand. 2003. Inhibition of complement activation decreases airway inflammation and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 168: 1333-1341. (Pubitemid 37487328)
7. Brostoff, J., J. F. Mowbray, A. Kapoor, S. J. Hollowell, M. Rudolf, and K. B. Saunders. 1976. 80% of patients with intrinsic asthma are homozygous for HLA W6. Is intrinsic asthma a recessive disease? Lancet 2: 872-873.
8. Hasegawa, K., M. Tamari, C. Shao, M. Shimizu, N. Takahashi, X. Q. Mao, A. Yamasaki, F. Kamada, S. Doi, H. Fujiwara, et al. 2004. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum. Genet. 115: 295-301. (Pubitemid 39247870)
9. Fregonese, L., F. J. Swan, A. van Schadewijk, M. Dolhnikoff, M. A. Santos, M. R. Daha, J. Stolk, T. Tschernig, P. J. Sterk, P. S. Hiemstra, et al. 2005. Expression of the anaphylatoxin receptors C3aR and C5aR is increased in fatal asthma. J. Allergy Clin. Immunol. 115: 1148-1154. (Pubitemid 40824582)
10. Humbles, A. A., B. Lu, C. A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406: 998-1001.
11. Drouin, S. M., D. B. Corry, J. Kildsgaard, and R. A. Wetsel. 2001. Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 167: 4141-4145. (Pubitemid 32954285)
12. Schmidt, C. Q., A. P. Herbert, H. G. Hocking, D. Uhrín, and P. N. Barlow. 2008. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin. Exp. Immunol. 151: 14-24. (Pubitemid 350231000)
13. Pickering, M. C., H. T. Cook, J. Warren, A. E. Bygrave, J. Moss, M. J. Walport, and M. Botto. 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31: 424-428. (Pubitemid 35154455)
14. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87: 3982-3986.
15. de Córdoba, S. R., and E. G. de Jorge. 2008. Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clin. Exp. Immunol. 151: 1-13.
16. Thurman, J. M., D. Ljubanovic, C. L. Edelstein, G. S. Gilkeson, and V. M. Holers. 2003. Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J. Immunol. 170: 1517-1523. (Pubitemid 36139523)
17. Watanabe, H., G. Garnier, A. Circolo, R. A. Wetsel, P. Ruiz, V. M. Holers, S. A. Boackle, H. R. Colten, and G. S. Gilkeson. 2000. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J. Immunol. 164: 786-794. (Pubitemid 30043702)
18. Xiao, H., A. Schreiber, P. Heeringa, R. J. Falk, and J. C. Jennette. 2007. Alternative complement pathway in the pathogenesis of disease mediated by antineutrophil cytoplasmic autoantibodies. Am. J. Pathol. 170: 52-64. (Pubitemid 47339189)
19. Huang, Y., F. Qiao, C. Atkinson, V. M. Holers, and S. Tomlinson. 2008. A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury. J. Immunol. 181: 8068-8076.
20. Atkinson, C., F. Qiao, H. Song, G. S. Gilkeson, and S. Tomlinson. 2008. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice. J. Immunol. 180: 1231-1238.
21. Takeda, K., S. W. Dow, N. Miyahara, T. Kodama, T. Koya, C. Taube, A. Joetham, J. W. Park, A. Dakhama, R. M. Kedl, and E. W. Gelfand. 2009. Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation. J. Immunol. 183: 181-190.
22. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316. (Pubitemid 44628849)
23. Bowser, C., D. P. Erstein, J. I. Silverberg, M. Nowakowski, and R. Joks. 2010. Correlation of plasma complement split product levels with allergic respiratory disease activity and relation to allergen immunotherapy. Ann. Allergy Asthma Immunol. 104: 42-49.
24. Nakano, Y., S. Morita, A. Kawamoto, T. Suda, K. Chida, and H. Nakamura. 2003. Elevated complement C3a in plasma from patients with severe acute asthma. J. Allergy Clin. Immunol. 112: 525-530. (Pubitemid 37108556)
25. Krug, N., T. Tschernig, V. J. Erpenbeck, J. M. Hohlfeld, and J. Köhl. 2001. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit. Care Med. 164: 1841-1843. (Pubitemid 33152317)
26. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Köhl, L. Wahl, D. Kuperman, S. Germer, et al. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1: 221-226.
27. Köhl, J., R. Baelder, I. P. Lewkowich, M. K. Pandey, H. Hawlisch, L. Wang, J. Best, N. S. Herman, A. A. Sproles, J. Zwirner, et al. 2006. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116: 783-796. (Pubitemid 43326888)
28. Drouin, S. M., M. Sinha, G. Sfyroera, J. D. Lambris, and R. A. Wetsel. 2006. A protective role for the fifth complement component (c5) in allergic airway disease. Am. J. Respir. Crit. Care Med. 173: 852-857.
29. Lukacs, N. W., M. M. Glovsky, and P. A. Ward. 2001. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L512-L518.
30. Peng, T., L. Hao, J. A. Madri, X. Su, J. A. Elias, G. L. Stahl, S. Squinto, and Y. Wang. 2005. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J. Clin. Invest. 115: 1590-1600. (Pubitemid 40814667)
31. Atkinson, C., H. Song, B. Lu, F. Qiao, T. A. Burns, V. M. Holers, G. C. Tsokos, and S. Tomlinson. 2005. Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J. Clin. Invest. 115: 2444-2453. (Pubitemid 41266206)
32. Song, H., C. He, C. Knaak, J. M. Guthridge, V. M. Holers, and S. Tomlinson. 2003. Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation. J. Clin. Invest. 111: 1875-1885. (Pubitemid 38057732)
33. Chen, M., M. R. Daha, and C. G. Kallenberg. 2010. The complement system in systemic autoimmune disease. J. Autoimmun. 34: J276-J286.
34. He, C., M. Imai, H. Song, R. J. Quigg, and S. Tomlinson. 2005. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J. Immunol. 174: 5750-5757. (Pubitemid 40593218)